|
|
|
Volumn 24, Issue 6 SUPPL. 19, 1997, Pages
|
|
Paclitaxel pharmacology and other tumor types
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 ETHYNYLURACIL;
BIRICODAR;
CARBOPLATIN;
CISPLATIN;
CYTOCHROME P450;
DOCETAXEL;
DOXORUBICIN;
FLUOROURACIL;
FOLINIC ACID;
HYDROXYUREA;
IFOSFAMIDE;
NAVELBINE;
PACLITAXEL;
UFT;
UNCLASSIFIED DRUG;
VALSPODAR;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BLADDER CANCER;
BONE MARROW SUPPRESSION;
BREAST CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL TRIAL;
DOSE CALCULATION;
DRUG DISPOSITION;
DRUG EFFICACY;
ESOPHAGUS CANCER;
HEAD AND NECK CANCER;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
KAPOSI SARCOMA;
LUNG CANCER;
OVARY CANCER;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
TESTIS CANCER;
ALKYLATING AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DOXORUBICIN;
ENDOMETRIAL NEOPLASMS;
ESOPHAGEAL NEOPLASMS;
FEMALE;
FLUOROURACIL;
HEAD AND NECK NEOPLASMS;
HUMANS;
LYMPHOMA;
MALE;
NEOPLASMS;
NEOPLASMS, UNKNOWN PRIMARY;
PACLITAXEL;
PLATINUM COMPOUNDS;
SARCOMA, KAPOSI;
STOMACH NEOPLASMS;
TESTICULAR NEOPLASMS;
URINARY BLADDER NEOPLASMS;
UTERINE CERVICAL NEOPLASMS;
VINBLASTINE;
|
|
EID: 0031442834
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (78)
|
|
References (98)
|
